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Abstract Palmitoylation of K-subunits in heterotrimeric G
proteins has become a research object of growing attention.
Following our recent report on the acylation of the mono-
palmitoylated GK12 [Ponimaskin et al., FEBS Lett. 429 (1998)
370^374], we report here on the identification of three
palmitoylation sites in the second member of the G12 family,
GK13, and on the biological significance of fatty acids on the
particular sites. Using mutants of K13 in which the potentially
palmitoylated cysteine residues (Cys) were replaced by serine
residues, we find that Cys-14, Cys-18 and Cys-37 all serve as
palmitoylation sites, and that the mutants lacking fatty acids are
functionally defective. The following biological functions of GK13
were found to be inhibited: coupling to the PAR1 thrombin
receptor, cell transformation and actin stress fiber formation.
Results from established assays for the above functions with a
series of mutants, including derivatives of the constitutively
active mutant GK13Q226L, revealed a graded inhibitory response
on the above mentioned parameters. As a rule, it appears that
palmitoylation of the N-proximal sites (e.g. Cys-14 and Cys-18)
contributes more effectively to biological function than of the
acylation site located more internally (Cys-37). However, the
mutant with Cys-37 replaced by serine is more severely inhibited
in stress fiber formation (80%) than in cell transformation
(50%), pointing to the possibility of a differential involvement of
the three palmitoylation sites in GK13. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Heterotrimeric G proteins, composed of GK- and GLQ-sub-
units, couple activated heptahelical receptors to e¡ector mol-
ecules such as adenylyl cyclases, phosphatidylinositol-speci¢c
phospholipase C, cGMP, phosphodiesterase and ion channels
[1^4]. Receptor activation causes release of GDP from GK,
allowing GTP to bind. GK and GLQ dissociate, and both sub-
units remain activated until the intrinsic GTPase activity of
GK hydrolyses GTP to GDP. In order to function as signal
transducer, G proteins have to be localized at the cytoplasmic
face of the plasma membrane. Covalent lipid modi¢cations on
the K-subunits and on the heterodimeric LQ-subunit are one of
the important factors mediating such membrane association.
Isoprenylation at the N-terminus of the Q-polypeptide pro-
vides a strong membrane anchor for LQ-subunits [5,6]. In ad-
dition, all G protein K-subunits so far examined are modi¢ed
at or near their N-termini by covalent attachment of myristic
and/or palmitic acids [7^9]. Unlike myristate, which is stably
bound to the protein in an amide linkage, palmitate is at-
tached via a labile thioester linkage to a cysteine residue.
With the ¢nding that palmitoylation is a dynamic process, it
is now accepted that repeated cycles of palmitoylation and
depalmitoylation could be involved in regulating the signalling
activity and function of G protein K-subunits [10]. Another
possible function of palmitoylation discussed more recently is
the targeting of K-subunits to subdomains of the plasma mem-
brane as rafts or caveolae [11^13].
The more recently identi¢ed G12 family of heterotrimeric G
proteins is comprised of the pertussis toxin insensitive GK12
and GK13 subunits which are expressed ubiquitously [14] and
show a relatively slow rate of guanine nucleotide exchange
and hydrolysis [15,16]. G12=13 are activated through various
receptors, including those for thrombin, thromboxane A2, an-
giotensin AT1A and lysophosphatidic acid (LPA) [15,17,18].
Studies with constitutively activating mutants have resulted
in the identi¢cation of several novel functions of GK12 and
GK13, including transforming activity, activation of c-Jun N-
terminal kinase cascade [19,20], regulation of Na/H ex-
changer [21], induction of apoptosis [22] and stimulation of
the Rho-dependent stress ¢ber formation and focal adhesion
assembly [23]. Whereas there are clear similarities in the e¡ects
induced by GK12 and GK13, di¡erences in the signalling mech-
anisms have also been reported [24]. Recently it was shown
that a nucleotide exchange factor (GEF) for Rho, GEF115,
could be directly activated by GK13 but not by GK12 [25]. On
the other hand, GEF115 functions as a GTPase-activating
protein for both GK12 and GK13.
Here we report experiments designed to examine the e¡ect
of acylation on the signalling function of the GK13 subunit. By
site-directed mutagenesis, we show that GK13 is palmitoylated
on three cysteine residues Cys-14, Cys-18 and Cys-37, two of
which (Cys-14 and Cys-18) represent predominant binding
sites for palmitate. We present evidence that palmitoylation
of GK13 is required for Rho-dependent stress ¢ber formation
and that transforming activity of constitutively active GK13 is
drastically impaired when fatty acid binding sites on the GK13
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are mutated. Furthermore, we show that acylation is not re-
quired for heterotrimer binding to the membrane and also
present evidence that a lack of palmitoylation in the GK13
subunit results in signi¢cant inhibition of coupling to the
PAR1 thrombin receptor.
2. Materials and methods
2.1. Recombinant DNA and site-directed mutagenesis
The construction of pVL1392 vector encoding the GK13 wild type
(GK13wt) was described previously [26]. The GK13 mutants (GK13M1;
M2; M3; M1-2; M1-2-3) with the substitution of serine for cysteine
14; 18; 37; 14 and 18; 14, 18 and 37, respectively, were performed by
‘Chameleon1’ double-stranded, site-directed mutagenesis kit (Strata-
gene) according to the manufacturer’s protocol or by overlap-exten-
sion PCR mutagenesis using an oligonucleotide containing the muta-
tion corresponding to the above substitutions. For expression in
mammalian cells, cysteine mutants were introduced into constitutively
active GK13 mutant (Q226L; GK13QL) cloned in pCDNA3 plasmid
(Invitrogen). The ¢nal mutants were veri¢ed by DNA sequencing.
Recombinant baculoviruses encoding L1- and Q2-subunits were kindly
provided by P. Gierschik (Ulm, Germany), and those encoding the
human thrombin receptor and GK13 were recently described [26,27].
2.2. Metabolic labeling and immunoprecipitation
Spodoptera frugiperda (Sf9) cells in 3.5 mm dishes were infected
with recombinant baculoviruses at a multiplicity of infection of at
least one for each type of virus. After 48 h, Sf9 cells were labeled
with Tran[35S]-label (s 1000 Ci/mmol, ICN) or [3H]palmitic acid (30^
60 Ci/mmol, DuPont NEN) and immunoprecipitated as described
previously [28]. Antibodies AS343 raised against the C-terminal do-
main of GK13 (amino acids 367^377, LHDNLKQLMLQ) were used
for immunoprecipitation [14,29]. Antibodies were kindly provided
from the laboratory of G. Schultz (Berlin, Germany).
2.3. Cell fractionation
Infected and methionine-labeled Sf9 cells were washed once with
phosphate-bu¡ered saline, resuspended in extraction bu¡er (10 mM
Tris^HCl (pH 7.4), 1 mM EDTA, 150 mM NaCl, 1 mM dithiothrei-
tol) and homogenized by soni¢cation. The homogenate was centri-
fuged at 5000Ug for 5 min, and the resulting supernatant fraction
was centrifuged at 125 000Ug at 4‡C for 30 min. The ¢nal fractions
were diluted in 2URIPA bu¡er (2% Triton X-100, 2% deoxycholate,
0.2% sodium dodecyl sulfate (SDS), 300 mM NaCl, 40 mM Tris^HCl
(pH 7.4), 20 mM EDTA, 20 mM iodoacetamide) prior to immuno-
precipitation.
2.4. Assay for [35S]GTPQS binding
Agonist-promoted binding of [35S]guanosine 5P-(3-O-thio)triphos-
phate to GK13 wild type as well as the di¡erent fatty acid-de¢cient
mutants was performed according to the method described by Poni-
maskin et al. [28]. Brie£y, membranes from Sf9 cells expressing the
thrombin receptor (PAR1) and/or G protein subunits were resus-
pended in 55 Wl of 50 mM Tris^HCl (pH 7.4) containing 2 mM
EDTA, 100 mM NaCl, 3 mM MgCl2 and 1 WM GDP. After adding
[35S]GTPQS (1300 Ci/mmol, DuPont NEN) to a ¢nal concentration of
30 nM, samples were incubated for 5 min at 30‡C in the absence or
presence of thrombin receptor activator SFLLRNPNDKYEPF (Sig-
ma). The reaction was terminated by adding 600 Wl of 50 mM Tris^
HCl (pH 7.5) containing 20 mM MgCl2, 150 mM NaCl, 0.5% NP-40,
200 Wg/ml aprotinin, 100 WM GDP and 100 WM GTP for 30 min on
ice. The samples were incubated for 20 min with 150 Wl of a 10%
suspension of Pansorbin cells (Calbiochem) to remove non-speci¢cally
bound proteins followed by 1 h at 4‡C with 10 Wl of antiserum AS343
directed against GK13 subunits, which had been preincubated with 100
Wl of 10% suspension of protein A-Sepharose. Immunoprecipitates
were washed three times, boiled in 0.5 ml of 0.5% SDS, before 4 ml
of Ecolite+(ICN) was added and radioactivity measured by scintilla-
tion spectrometry.
2.5. Focus formation assay
Focus formation assays were performed as described previously
[30]. Brie£y, Rat-1 cells (60 mm dishes in triplicate) were transfected
with cDNA constructs and cultured for 14 days in the presence of 5%
fetal calf serum (FCS). Foci were stained with Giemsa and counted.
Three independent experiments were performed.
2.6. Stress ¢ber formation assay
Swiss 3T3 cells were seeded on glass coverslips and grown over-
night. To obtain quiescent and serum-starved cells, cultures were in-
cubated with DMEM supplemented with 0.1% FCS for 24 h, followed
by 48 h incubation in DMEM without serum. Plasmids were injected
into the nucleus together with Texas Red dextran (5 mg/ml) to visual-
ize injected cells. Injected cells were incubated for 12 h followed by
¢xation with 4% paraformaldehyde for 20 min and permeabilization
with 0.2% Triton X-100 for 5 min. To visualize the polymerized actin,
cells were stained with 0.5 Wg/ml £uorescein isothiocyanate-phalloidin
for 40 min and examined using an inverted microscope (Zeiss Axio-
vert 100). To determine the percentage of stress ¢ber positive cells,
only cells detected by their Texas Red £uorescence were counted. A
minimum of 100 cells were investigated in each case and experiments
were repeated at least twice.
3. Results and discussion
3.1. Palmitoylation sites on GK13
We had previously shown that GK13 is acylated and the
fatty acid bond is sensitive to neutral hydroxylamine and re-
ducing agents, demonstrating a thioester-type fatty acid link-
age [26]. Inspection of the amino acid sequence of GK13 re-
vealed three potential acylation sites located near the N-
terminus: cysteine residues 14, 18 and 37. A role for these
Cys residues in palmitoylation was tested by site-directed mu-
tagenesis. Cysteine residues were mutated to serine either in-
dividually to produce mutants M1 (C14S), M2 (C18S) or M3
(C37S), double-mutated (M1-2) or all three cysteines were
replaced (M1-2-3). Results of labeling experiments with
[35S]methionine followed by immunoprecipitation with GK13
antibodies shown in Fig. 1 (left panel) indicate that GK13 Cys
Fig. 1. GK13 is palmitoylated on three cysteine residues (Cys-14,
Cys-18 and Cys-37) but mainly on Cys-14 and Cys-18. GK13 wild
type (GK13wt) and di¡erent GK13 mutants (GK13M1; M2; M3; M1-
2; M1-2-3) with the substitution of serine for cysteine 14; 18; 37;
14 and 18; 14, 18 and 37, respectively, were expressed in Sf9 cells,
labeled either with [35S]methionine/cysteine (left panel) or
[3H]palmitic acid (right panel) and subjected to immunoprecipitation
with antibodies AS343 raised against GK13, SDS^PAGE and £uo-
rography. Exposure time is 1 day for labeling with [35S]methionine/
cysteine and 3 weeks for labeling with [3H]palmitate. In the lower
panel, the N-terminal sequences of GK13wt and their Cys mutants
are given in single-letter code.
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mutants were as e⁄ciently expressed as GK13wt. The reason
for the more slowly migrating bands of GK13 in the gel with
all mutants except M1 is unknown at present. One possibility
is the presence of di¡erently folded protein populations, be-
cause the gel shown in Fig. 1 was run under non-reducing
conditions (in the absence of mercaptoethanol). After labeling
with [3H]palmitate, acylation levels di¡ered for all mutants
investigated (Fig. 1, right panel). Importantly, the replacement
of either single Cys-14 (M1) and Cys-18 (M2) or both these
residues (M1-2) resulted in a similarly strong reduction of
palmitoylation, whereas mutation of cysteine residue 37
(M3) produced only a minor decrease in palmitoylation. Mu-
tant M1-2-3 with all three cysteine residues replaced to serine
failed to incorporate any detectable levels of radiolabeled pal-
mitate even after prolonged exposure time. These results dem-
onstrate the involvement of all three cysteine residues Cys-14,
Cys-18, Cys-37 in palmitoylation of GK13 and suggest that
cysteine residues 14 and 18 represent the main linkage sites
for covalent attachment of palmitate.
GK13 shares a 67% sequence identity to GK12 and both
proteins demonstrate clear similarities in their signalling func-
tions. In spite of this fact, the amino-terminus of GK13 is quite
distinct when compared to GK12. The N-terminus of GK13 is
shorter and possesses three apparent acylation sites, whereas
GK12 has only one palmitoylated cysteine residue at position
12 [28,31]. The distinct di¡erences between GK12 and GK13
signalling reported recently for activation of GEF115 [24,25]
could potentially be caused by the distinctive palmitoylation
of these two subunits.
3.2. Palmitoylation in£uences the coupling of G12 to the PAR1
thrombin receptor
In order to determine whether palmitoylation of GK13 is
required for signalling, we studied a number of signalling
events accessible to quantitative assays. Firstly, we compared
the interaction of the thrombin receptor with wild type GK13
as well as with their fatty acid-de¢cient mutants in membrane
preparations from infected Sf9 insect cells. PAR1 receptor, the
GK- and GLQ-subunits were co-expressed from recombinant
baculoviruses and then agonist-promoted binding of
[35S]GTPQS was measured in the membranes from transfected
cells. Using this system, we found for GK13wt a 5.5-fold in-
crease in the binding of [35S]GTPQS after co-expression of
thrombin receptor in response to the agonist (Fig. 2). When
GK13M1, M2, M1-2 or M1-2-3 instead of the GK13wt were
expressed beside the thrombin receptor and LQ-subunits, in-
corporation of [35S]GTPQS after stimulation with agonist was
severely reduced. In contrast, after expression of GK13M3
agonist stimulated [35S]GTPQS binding was only moderately
impaired when compared to the control values obtained with
GK13wt (Fig. 2). These di¡erences in the incorporation e⁄-
ciency were not due to a di¡erent subcellular distribution
between GK13wt and its acylation-de¢cient mutants. On the
one hand, subcellular fractionation of Sf9 cells transfected
with GK13 revealed that in the absence of LQ-subunits about
one half of GK13wt and more than two thirds of GK13M1-2-3
are present in the soluble fraction, indicating that palmitoyla-
tion contributes to membrane binding. However, co-expres-
sion of LQ targeted more than half of GK13M1-2-3 to the
membrane, making the intracellular distribution of the non-
palmitoylated mutants similar to that of wild type (not
shown). Thus, membrane binding of GK13 seems to require
acylation only when it is solitary, while protein^protein inter-
actions and the prenyl group present in the Q-subunit predom-
inate in membrane attachment of the full heterotrimer.
These data are consistent with our recent observation that
the thrombin receptor PAR1 couples to G proteins of the G12
family [28]. They also suggest that acylation of cysteine resi-
dues 14 and 18, but not of cysteine 37 is essential for normal
communication with the thrombin receptor and indicate that
the ability of GK13 to be activated trough the receptor corre-
lates with its level of palmitoylation.
3.3. GK13 requires acylation for its transforming activity
We have shown previously that a GTPase-de¢cient consti-
tutively activated mutant of GK13 (Q226L; GK13QL) induces
neoplastic transformation of NIH3T3 and Rat-1 cells, which
is a cellular end point for activation of a GK13-mediated cas-
cade [30]. To determine if lipid modi¢cation is required for
GK13-dependent neoplastic transformation, we have compared
focus-forming activity of GK13QL with that of GK13QL/M1,
GK13QL/M2, GK13QL/M3 or GK13QL/M1-2-3 (Fig. 3A,B).
Control experiments demonstrated that in Rat-1 cells,
GK13QL induced foci formation, whereas GK13wt did not
lead to cell transformation (Fig. 3B). Inspecting the fatty
acid-de¢cient mutants resulted in a di¡erential picture. While
GK13QL/M1, GK13QL/M2 and GK13QL/M1-2-3 mutants lost
their ability to induce foci formation (Fig. 3), GK13QL/M3
mutant with cysteine 37 replaced to serine was still able to
induce focus formation in about 50% of the cell population
when compared to the control cells transformed with GK13QL
(Fig. 3). These results suggest that the palmitoylation sites or
presence of Cys-14 and Cys-18 are required for GK13-induced
focus formation while Cys-37 seems to be less important for
this biological activity. These results are in line with those of
Wedegaertner et al. [32] who reported that an acylation-de¢-
cient mutant of Gas can partially activate its downstream
e¡ector but this is inadequate to activate the cascade. How-
Fig. 2. Receptor-promoted binding of [35S]GTPQS to GK13wt and its
di¡erent acylation-de¢cient mutants. Membranes were prepared
from Sf9 cells expressing proteins as indicated below. [35S]GTPQS
binding was assessed after incubation with or without 30 WM
thrombin receptor activator (SFLLRNPNDKYEPF) followed by
immunoprecipitation using GK13-speci¢c antiserum. Data points rep-
resent the mean þ S.E.M. from three independent experiments. Sta-
tistically signi¢cant increases from values obtained with GK13wt or
with GK13M3 are noted (*P6 0.01).
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Fig. 3. Focus formation in Rat-1 cells expressing constitutively ac-
tive GK13 and its acylation-de¢cient mutants. A: Rat-1 cells were
transiently transfected with cDNA as indicated using LipofectAM-
INE 2000 (Gibco), empty vector was added to each transfection to
keep the total amount of DNA at equivalent levels. Cells were
plated on 60 mm dishes and after 14 days incubation stained with
Giemsa. B: For quanti¢cation, foci on each dish were counted. The
mean values þ S.D. from three separate experiments are shown. One
set of duplicates is shown.
Fig. 3 (continued).
Fig. 4. Palmitoylation is involved in stress ¢ber formation induced
by GK13QL. Quiescent Swiss 3T3 cells were nuclear microinjected
with pCDNA3-GK13QL or pCDNA3-GK13QL/Cys mutants in the
presence of Texas Red. A: For quanti¢cation of stress ¢ber forma-
tion, microinjected cells were ¢rst identi¢ed by their Texas Red £uo-
rescence, and then the fraction of stress ¢ber positive cells was
counted. The mean value of triplicates þ S.D. is shown. B: Stress ¢-
ber assembly induced by GK13QL (left panel) or by GK13QL/M1-2-3
(right panel) was monitored using rhodamine-phalloidin. Typical ex-
amples of stress ¢ber in individual cells are shown.
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ever, GK13 has three palmitoylation sites as compared to one
in many other K-subunits [10,32,33]. This allows to test for the
biological signi¢cance of fatty acids located in di¡erent places
along the N-terminal domain. From the data in Fig. 3, it
appears that palmitoylation of K13 contributes to cell trans-
formation most e¡ectively when it occurs most proximally to
the N-terminus.
3.4. Acylation of GK13 is involved in stress ¢ber formation
It has recently been reported that GK13 mediates LPA-in-
duced actin polymerization in a Rho-dependent manner
[17,34]. Similarly, expression of a GTPase-de¢cient constitu-
tively activated mutant of GK13 (Q226L; GK13QL) triggers
actin polymerization in a receptor-independent manner [23].
In order to characterize the functional role of palmitoylation
of GK13 in the Rho-dependent signalling, we compared the
ability of GK13QL and a series of GK13QL/Cys mutants to
form actin stress ¢bers. We ¢rst expressed the constitutively
activated GK13QL mutant in Swiss 3T3 ¢broblasts by micro-
injecting expression plasmids into quiescent cells. Fig. 4A
demonstrates that GK13QL stimulates the formation of actin
stress ¢bers in about 80% of the cells, whereas the injection of
GK13wt displayed the same low basal level of stress ¢bers as in
non-injected cells (not shown). When GK13QL/M1, GK13QL/
M2 or GK13QL/M1-2-3 were expressed, the stimulation of
stress ¢ber formation was drastically reduced (Fig. 3A). Inter-
estingly, expression of the GTPase-de¢cient form of GK13
with cysteine 37 replaced by serine (GK13QL/M3) reduced
stress ¢ber induction to less than 20% of the control level.
As with cell transformation, principally stress ¢ber formation
through GK13 is most severely a¡ected when fatty acids are
deleted from an N-proximal location. However, in this case
the innermost acylation site may have a more prominent role
as with the induction of cell transformation.
Taken together, our results with recombinant GK13 are con-
sistent with the current notion that palmitoylation is a com-
mon feature of GK-subunits (e.g. GKs, GKq, GK11, GKz and
GK12 ([28], for review see [33])) which signi¢cantly contributes
to the regulation of signalling by G proteins. Extending this
general conclusion, we suggest that the position of palmitoy-
lation sites is of functional importance. Cysteine residues clos-
er to the N-terminus may contribute more e¡ectively to sig-
nalling than those located more internally. Mutational shifting
of palmitoylation sites along the N-terminal domain of K-sub-
units provides a promising tool for testing this hypothesis in
the future.
4. Note added in proof
In the process of publishing our data, a paper appeared on
the same subject matter and with results very similar to ours:
Bhattacharyya, R. and Wedegaertner, P.B. (2000) J. Biol.
Chem. 275, 14992^14999.
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